Immunoepidemiological and in vitro studies of possible relationships between Australia antigen and hepatocellular carcinoma.
D000818:Animals; D000917:Antibody Formation; D001344:Autopsy; D001706:Biopsy; D006528:Carcinoma, Hepatocellular / Q000276:immunology*; D002471:Cell Transformation, Neoplastic; D002478:Cells, Cultured; D002869:Chromosome Aberrations / Q000187:drug effects; D003588:Cytopathogenic Effect, Viral; D004381:Duodenal Ulcer / Q000276:immunology; D005455:Fluorescent Antibody Technique; D006511:Hepatitis B Antigens / Q000276:immunology; D006515:Hepatitis B virus / Q000276:immunology*; D006801:Humans; D005779:Immunodiffusion; D037102:Lectins / Q000494:pharmacology; D008101:Liver Abscess, Amebic / Q000276:immunology; D008103:Liver Cirrhosis / Q000276:immunology; D008113:Liver Neoplasms / Q000276:immunology*; D008213:Lymphocyte Activation / Q000187:drug effects; D009368:Neoplasm Transplantation; D051381:Rats; D013634:Tannins / Q000494:pharmacology
D006511:Hepatitis B Antigens; D037102:Lectins; D013634:Tannins